Falintolol
Изглед
![]() | |
Nazivi | |
---|---|
Preferisani IUPAC naziv
(2 | |
Identifikacija | |
3D model (Jmol)
|
|
ChemSpider | |
UNII | |
| |
Svojstva | |
C12H24N2O2 | |
Molarna masa | 228,34 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
Reference infokutije | |
Falintolol je agonist beta-adrenergičkog receptora.[3]
Reference
[уреди | уреди извор]- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Conti P, Dallanoce C, De Amici M, De Micheli C, Klotz KN (април 1998). „Synthesis of new delta 2-isoxazoline derivatives and their pharmacological characterization as beta-adrenergic receptor antagonists”. Bioorganic & Medicinal Chemistry. 6 (4): 401—8. PMID 9597184. doi:10.1016/s0968-0896(97)10051-7.